Direct measurement of T cell receptor affinity and sequence from naïve antiviral T cells

Shu-Qi Zhang1, Patricia Parker2, Ke-Yue Ma3

  • 1McKetta Department of Chemical Engineering, University of Texas at Austin, Austin, TX 78712, USA.

Insights

We developed a new test (iTAST) to measure T cell receptor (TCR) affinity and sequence simultaneously. Older individuals have fewer high-affinity T cells, suggesting age impacts immune response and potentially adoptive T cell therapy effectiveness.

Area of Science:

  • Immunology
  • Cellular Biology
  • Biotechnology

Background:

  • T cells utilize diverse T cell receptors (TCRs) to identify and eliminate infected or cancerous cells.
  • TCR affinity to cognate antigen is crucial for T cell responses, impacting immunotherapy and immune profiling.
  • Current methods lack simultaneous measurement of TCR affinity and sequence from single primary cells.

Purpose of the Study:

  • To introduce a novel method, the in situ TCR affinity and sequence test (iTAST), for simultaneous measurement of TCR affinity and sequence.
  • To analyze the affinity range and sequence diversity of antigen-specific T cells in primary human blood.
  • To investigate age-related differences in T cell repertoire and high-affinity T cell frequency.

Main Methods:

  • Development and application of the in situ TCR affinity and sequence test (iTAST).
  • Simultaneous measurement of TCR affinity and sequence from single primary CD8(+) T cells in human blood.
  • Analysis of T cell repertoires in pathogen-inexperienced individuals, comparing young and older cohorts.

Main Results:

  • Primary antigen-specific T cells exhibit a broad, 1000-fold affinity range with diverse TCR sequences.
  • Older individuals show a reduced frequency of high-affinity T cells compared to younger individuals.
  • Evidence of age-related T cell attrition potentially creating gaps in the immune repertoire.

Conclusions:

  • iTAST enables simultaneous measurement of TCR affinity and sequence from single primary T cells.
  • The T cell repertoire shows significant age-related decline in high-affinity cells.
  • iTAST can facilitate ex vivo selection of high-affinity TCRs for adoptive immunotherapy and immune monitoring.